Convulsions associated with the use of a synthetic cannabinoid product.
about
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsJWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Emergency physicians' knowledge of cannabinoid designer drugsSpicing things up: synthetic cannabinoids.Toxicology and management of novel psychoactive drugs.The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.Synthetic Pot: Not Your Grandfather's Marijuana.Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor.Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.Emerging drugs of abuse: what was new yesterday is new today.The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice.A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication.Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.Driving under the influence of synthetic cannabinoids ("Spice"): a case series.AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS.Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologuesBehavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ-THC in Rats
P2860
Q27010555-BBEC0FFB-F1FF-4E6D-9099-6C82CF08F38CQ34098379-69778F39-8F90-469B-AC14-1CF49CDF9B8AQ34296844-48D188CE-2732-4286-BBD1-AA4E2D5B5D69Q34336690-47525FF7-7ED7-457A-829A-B5568E042A55Q34617484-C0CA1B8D-CA75-44B0-920F-7CA20CBA7C92Q37213666-20BB343C-FF1A-4BEA-8539-B09EAA090AF7Q37237996-D053F52C-500C-4581-812D-F93DDE3770ABQ38254814-A6D9097E-1579-4C20-BEF6-C7455924B2EDQ38317405-8808046C-4801-4584-A997-0E1F8149F094Q39120303-47674B3C-358F-408C-9A20-0030E9F211B7Q41248905-993DFBAB-E954-405B-A984-0CE9F692BF80Q41621185-1BBEE0A6-22F4-401A-BE74-DFC9478EAE2CQ41774329-581FF271-6D66-4223-A501-6A8DFF57DD77Q42870428-6323E594-9793-4121-A117-3898292006E3Q44004239-4F192947-6126-48EF-8637-3694CB716C40Q47113406-E6557C84-DB21-4D22-8DC1-AED5C81FBC0CQ47143238-9950C933-2897-420B-8282-832272BC0706Q48301733-E000A4EB-4B49-48F0-BAB0-9D1730D01C41Q48351076-7BA5836D-0552-47B7-A37C-5DA8FCEA7AAAQ48569237-2CDE8946-7CDD-4E5D-9D11-D23DC25468C7Q51026124-BAA3E9A0-845A-447F-B93E-AEC7E2ECA71EQ51100761-10BAB693-83D0-4017-BD4B-4EC4F7361B1FQ52301471-B2B2B31C-884D-44B2-AFAC-8A5B3B8B46B4Q53351420-90FFCC45-1413-4AF7-A6E9-4DA5BC445059Q58428304-3F400233-3590-40E6-A7CB-D4B511D4ECAFQ58573307-775C7F46-D195-4192-B754-120C995E0034
P2860
Convulsions associated with the use of a synthetic cannabinoid product.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Convulsions associated with the use of a synthetic cannabinoid product.
@ast
Convulsions associated with the use of a synthetic cannabinoid product.
@en
Convulsions associated with the use of a synthetic cannabinoid product.
@nl
type
label
Convulsions associated with the use of a synthetic cannabinoid product.
@ast
Convulsions associated with the use of a synthetic cannabinoid product.
@en
Convulsions associated with the use of a synthetic cannabinoid product.
@nl
prefLabel
Convulsions associated with the use of a synthetic cannabinoid product.
@ast
Convulsions associated with the use of a synthetic cannabinoid product.
@en
Convulsions associated with the use of a synthetic cannabinoid product.
@nl
P2860
P1476
Convulsions associated with the use of a synthetic cannabinoid product.
@en
P2093
Aaron B Schneir
Todd Baumbacher
P2860
P2888
P356
10.1007/S13181-011-0182-2
P577
2012-03-01T00:00:00Z
P5875
P6179
1010760821